Zo­genix wins in­side track at FDA with child­hood epilep­sy ‘break­through’

Zo­genix has won the FDA’s break­through ther­a­py des­ig­na­tion fol­low­ing some im­pres­sive Phase III da­ta an­nounced last fall, gain­ing an in­side track at the agency for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER